Pancreatic Cancer Research

ResearcherAsahikawa Medical UniversityActive in the last 2 years

Mikihiro Fujiya

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-4321-7774; OpenAlex author ID A5031845367, A5108411575, A5109599046. Sources: OpenAlex.

Their work

Papers
10 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
14
Papers, trials and grants by year

2019: 1 paper · 2020: 2 papers · 2021: 3 papers · 2022: 1 paper · 2023: none · 2024: 1 paper · 2025: none · 2026: 2 papers

Papers 10

  1. Extracellular vesicle-encapsulated microRNA-425 promotes tumor development and serves as a biomarker for pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s00535-026-02382-9↗
  2. Liquid Biopsy for Early Pancreatic Cancer Detection: Why Has It Not Yet Worked? Co-author DOI 10.3390/cancers18030525↗
  3. Liquid Biopsy for Pancreatic Cancer by Serum Extracellular Vesicle-Encapsulated Long Noncoding RNA HEVEPA. Co-author DOI 10.1097/mpa.0000000000002315↗
  4. Mutant GNAS limits tumor aggressiveness in established pancreatic cancer via antagonizing the KRAS-pathway. Co-author DOI 10.1007/s00535-021-01846-4↗
  5. Prognostic significance of skeletal muscle decrease in unresectable pancreatic cancer: Survival analysis using the Weibull exponential distribution model. Co-author DOI 10.1016/j.pan.2021.03.002↗
  6. Probiotic Aspergillus oryzae produces anti-tumor mediator and exerts anti-tumor effects in pancreatic cancer through the p38 MAPK signaling pathway. Last author DOI 10.1038/s41598-021-90707-4↗
  7. Long Non-Coding RNAs in Epithelial-Mesenchymal Transition of Pancreatic Cancer. Co-author DOI 10.3389/fmolb.2021.717890↗
  8. Resection for pancreatic cancer metastases contributes to survival: A case report with sequential tumor genotype profiling during the long-term postoperative c… Co-author DOI 10.1097/md.0000000000020564↗
  9. Probiotic‑derived ferrichrome inhibits the growth of refractory pancreatic cancer cells. First author DOI 10.3892/ijo.2020.5096↗
  10. Genetic analysis of postoperative recurrence of pancreatic cancer potentially owing to needle tract seeding during EUS-FNB. Co-author DOI 10.1055/a-1034-7700↗

Closest collaborators

The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yusuke Mizukami · 8 shared papers, 2019–2026 · strength 1.27
  2. Toshikatsu Okumura · 8 shared papers, 2019–2026 · strength 1.03
  3. Kenji Takahashi · 5 shared papers, 2021–2026 · strength 0.99
  4. Hidemasa Kawabata · 6 shared papers, 2019–2026 · strength 0.78
  5. Tetsuhiro Okada · 5 shared papers, 2019–2026 · strength 0.61
  6. Hiroki Sato · 5 shared papers, 2019–2024 · strength 0.56
  7. Yohei Kitano · 2 shared papers, 2024–2026 · strength 0.39
  8. Kazuya Koyama · 2 shared papers, 2024–2026 · strength 0.39
  9. Krushna Chandra Patra · 1 shared paper, 2026 · strength 0.33
  10. Hiroaki Konishi · 3 shared papers, 2020–2022 · strength 0.33
  11. Junpei Sasajima · 3 shared papers, 2019–2021 · strength 0.28
  12. Andrew Scott Liss · 1 shared paper, 2022 · strength 0.11
  13. Akemi Kita · 1 shared paper, 2020 · strength 0.09
  14. Yuko Omori · 1 shared paper, 2019 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.